PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-83129 Oracle Corporation CVE debrief

A vulnerability in Oracle Sales, a component of Oracle E-Business Suite, allows a low-privileged attacker with network access via HTTP to compromise the product. Successful attacks can result in unauthorized access to critical data or complete access to all Oracle Sales accessible data. The vulnerability affects versions 12.2.3-12.2.15 and has a CVSS 3.1 Base Score of 7.7 (Confidentiality impacts). Defenders should assess exposure and potential impact on Oracle Sales and Oracle E-Business Suite deployments.

Vendor
Oracle Corporation
Product
Oracle Sales
CVSS
HIGH 7.7
CISA KEV
Not listed in stored evidence
Original CVE published
2026-09-15
Original CVE updated
2026-11-03
Advisory published
2026-09-15
Advisory updated
2026-11-03

Who should care

Defenders responsible for Oracle Sales and Oracle E-Business Suite deployments should assess exposure and potential impact. They should prioritize verifying exposure of Oracle Sales versions 12.2.3-12.2.15 and assessing the impact of potential data access due to the vulnerability allowing low-privileged attackers to compromise the product and access critical data. Security teams and vulnerability management teams should also review the vulnerability andits

Why it matters

Defenders should prioritize verifying exposure of Oracle Sales versions 12.2.3-12.2.15 and assessing the impact of potential data access due to the vulnerability allowing low-privileged attackers to compromise the product and access critical data.

  • Potential unauthorized access to critical data
  • Possible complete access to all Oracle Sales accessible data
  • Need to verify exposure of affected versions
  • Priority on implementing compensating controls

Technical summary

The vulnerability in Oracle Sales, a component of Oracle E-Business Suite, allows a low-privileged attacker with network access via HTTP to compromise the product. Successful attacks can result in unauthorized access to critical data or complete access to all Oracle Sales accessible data. The CVSS 3.1 Base Score is 7.7 (Confidentiality impacts). The vulnerability affects versions 12.2.3-12.2.15 and has a significant impact on confidentiality. Defenders should prioritize verifying exposure of affected versions and assessing the impact of potential data access.

Defensive priority

Defenders should prioritize verifying exposure of Oracle Sales versions 12.2.3-12.2.15 and assessing the impact of potential data access.

Recommended defensive actions

  • Verify exposure of Oracle Sales versions 12.2.3-12.2.15
  • Assess potential data access impact
  • Implement compensating controls to limit data access
  • Review vendor guidance for Oracle Sales and Oracle E-Business Suite
  • Conduct vulnerability scanning for affected versions
  • Monitor for suspicious activity related to Oracle Sales
  • Track remediation progress and verify fixes

Evidence notes

The CVE record and NVD detail page provide information on the vulnerability, its impact, and affected versions. The vulnerability allows low-privileged attackers with network access via HTTP to compromise Oracle Sales and access critical data. Defenders should verify exposure of affected versions and assess potential data access impact. The information provided is based on the CVE record and NVD detail page, which offer details on the vulnerability and its severity.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-83129 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-83129

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-83129 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-83129

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.